Ubs Asset Management Americas Inc Harrow Health, Inc. Transaction History
Ubs Asset Management Americas Inc
- $417 Billion
- Q4 2024
A detailed history of Ubs Asset Management Americas Inc transactions in Harrow Health, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 61,940 shares of HROW stock, worth $1.79 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
61,940
Previous 32,678
89.55%
Holding current value
$1.79 Million
Previous $1.47 Million
41.46%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding HROW
# of Institutions
184Shares Held
21.1MCall Options Held
679KPut Options Held
1.27M-
Opaleye Management Inc. Boston, MA3.99MShares$116 Million26.33% of portfolio
-
Black Rock Inc. New York, NY2.15MShares$62.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.87MShares$54.2 Million0.0% of portfolio
-
Private Capital Management, LLC Naples, FL1.69MShares$49.1 Million6.85% of portfolio
-
Braidwell LP Stamford, CT907KShares$26.3 Million1.7% of portfolio
About HARROW HEALTH, INC.
- Ticker HROW
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 27,070,000
- Market Cap $784M
- Description
- Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...